Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 07, 2019 11:20AM
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 08, 2019 03:21PM
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
3
|
Zenith Epigenetics
|
Nov 21, 2018 03:32PM
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
6
|
Zenith Epigenetics
|
Nov 20, 2018 03:23PM
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
6
|
Zenith Epigenetics
|
Oct 05, 2020 07:08PM
|
Re: Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
|
7
|
Zenith Epigenetics
|
Oct 25, 2019 11:07AM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
4
|
Zenith Epigenetics
|
May 12, 2022 01:13PM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
4
|
Zenith Epigenetics
|
May 18, 2022 10:38AM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
4
|
Zenith Epigenetics
|
Jun 23, 2022 10:59AM
|
Re: Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program
|
3
|
Zenith Epigenetics
|
Mar 21, 2019 03:07PM
|
Re: Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program
|
4
|
Zenith Epigenetics
|
Mar 20, 2019 04:50PM
|
Re: Zenith Epigenetics Corp. Commences Operations
|
2
|
Zenith Epigenetics
|
Dec 08, 2015 11:23AM
|
Re: Zenith Epigenetics Corp. Commences Operations
|
2
|
Zenith Epigenetics
|
Dec 09, 2015 09:50AM
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
3
|
Zenith Epigenetics
|
Feb 15, 2022 11:37AM
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
4
|
Zenith Epigenetics
|
Feb 19, 2022 01:23PM
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
6
|
Zenith Epigenetics
|
Feb 07, 2022 12:27PM
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
3
|
Zenith Epigenetics
|
Feb 20, 2022 12:36PM
|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
6
|
Resverlogix Corp.
|
Feb 01, 2018 12:18PM
|
Re: Zenith funding???
|
5
|
Zenith Epigenetics
|
Jun 25, 2019 02:54PM
|
Re: Zenith funding???
|
3
|
Zenith Epigenetics
|
Jun 17, 2019 01:57PM
|